Publication | Open Access
Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway
28
Citations
21
References
2017
Year
MSI1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Akt signaling pathway, which provides a new strategy for the therapy of NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1